Boothbay Fund Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Sell
2,529
-4,214
-62% -$4.27M 0.03% 556
2025
Q4
$7.25M Buy
6,743
+1,669
+33% +$1.6M 0.11% 200
2025
Q3
$3.87M Sell
5,074
-348
-6% -$259K 0.06% 385
2025
Q2
$4.23M Buy
5,422
+1,153
+27% +$896K 0.08% 331
2025
Q1
$3.53M Sell
4,269
-1,188
-22% -$989K 0.09% 295
2024
Q4
$4.21M Buy
5,457
+3,138
+135% +$2.6M 0.1% 272
2024
Q3
$2.05M Sell
2,319
-4
-0.2% -$3.6K 0.05% 506
2024
Q2
$2.1M Sell
2,323
-1,028
-31% -$822K 0.05% 482
2024
Q1
$2.61M Sell
3,351
-4,577
-58% -$3.26M 0.05% 417
2023
Q4
$4.62M Sell
7,928
-3,885
-33% -$2.27M 0.12% 224
2023
Q3
$6.35M Sell
11,813
-3,431
-23% -$1.77M 0.15% 149
2023
Q2
$7.15M Sell
15,244
-27,056
-64% -$11.3M 0.16% 133
2023
Q1
$14.5M Buy
42,300
+23,049
+120% +$7.77M 0.3% 39
2022
Q4
$7.04M Buy
19,251
+7,290
+61% +$2.58M 0.16% 126
2022
Q3
$3.87M Buy
+11,961
New +$3.79M 0.1% 277
2021
Q4
Sell
-11,278
Closed -$2.61M 2068
2021
Q3
$2.61M Buy
11,278
+5,103
+83% +$1.26M 0.07% 349
2021
Q2
$1.42M Sell
6,175
-8,999
-59% -$1.81M 0.05% 541
2021
Q1
$2.83M Buy
15,174
+13,774
+984% +$2.69M 0.11% 219
2020
Q4
$236K Buy
+1,400
New +$209K 0.01% 1036
2016
Q4
Sell
-4,730
Closed -$380K 859
2016
Q3
$380K Buy
+4,730
New +$379K 0.08% 298
2015
Q4
Sell
-2,590
Closed -$217K 626
2015
Q3
$217K Buy
+2,590
New +$219K 0.1% 292

Other funds holding LLY

Boothbay Fund Management's LLY Position: Q1 2026 in Review

Boothbay Fund Management reduced its Eli Lilly (LLY) stake by 62% in Q1 2026, selling an estimated $4.27M and leaving 2,529 shares worth $2.33M. The position accounts for 0.03% of the portfolio, ranked #556.

Boothbay Fund Management first reported a position in LLY in Q3 2015 and has held it in 21 quarters since. The position peaked at $14.5M in Q1 2023. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Boothbay Fund Management held 2,529 shares of Eli Lilly worth $2.33M as of Q1 2026.
  • Boothbay Fund Management sold 4,214 Eli Lilly shares in Q1 2026, an estimated $4.27M.
  • Eli Lilly made up 0.03% of Boothbay Fund Management's portfolio in Q1 2026, its #556 holding.
  • Boothbay Fund Management first reported a position in Eli Lilly in Q3 2015 and has held it in 21 quarters since.
  • Boothbay Fund Management's Eli Lilly position peaked at $14.5M in Q1 2023.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.